Stocks
ABIOMED (ABMD) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | LTM ? | CAGR 5 years ? | |||||
| EBITDA, bln rub | ? | 246.9 | 190.6 | 500.5 | 472.9 | ||||
| Changes by years, y/y, % | -4% | -100% | +163% | +38.7% | |||||
ABIOMED. EBITDA US GAAP, bln rub
ABIOMED. EBITDA US GAAP, changes, %
ABIOMED. EBITDA US GAAP, sum by quarters, bln rub
ABIOMED (ABMD) EBITDA US GAAP (quarter values) |
||||||||
| 2022Q4 | 2022Q4 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 64.8 | 74.8 | 91.8 | 80.2 | 226.1 | 472.9 | |
| Changes by years, y/y, % | -6% | +9% | +34% | -57% | +240% | |||
| Changes by quarters, q/q, % | -9% | +15% | +23% | -13% | +182% | |||
